Hydroxychloroquine ‘doesn’t prevent’ COVID-19, reports trial
An NEJM study finds no difference between the anti-malaria drug and placebo when used as a prophylaxis
Hydroxychloroquine has been shown to be ineffective in preventing infection in people exposed to coronavirus, according to a widely anticipated clinical trial from the US.
The trial in the New England Journal of Medicine also found no serious side effects or heart problems from hydroxychloroquine use.
